Agios Pharmaceuticals
AGIO
AGIO
205 hedge funds and large institutions have $2.51B invested in Agios Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 48 funds opening new positions, 51 increasing their positions, 82 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
6% more call options, than puts
Call options by funds: $12.4M | Put options by funds: $11.8M
7.91% less ownership
Funds ownership: 110.34% → 102.43% (-7.9%)
38% less repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 82
Holders
205
Holding in Top 10
3
Calls
$12.4M
Puts
$11.8M
Top Buyers
| 1 | +$43M | |
| 2 | +$30.9M | |
| 3 | +$27.6M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$16.8M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$16.2M |
Top Sellers
| 1 | -$36.9M | |
| 2 | -$31.9M | |
| 3 | -$31.7M | |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$27.2M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$26M |